Healthcare

Image

Global Contrast Media Injectors Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Mar 2022
  • Global
  • 350 Pages
  • No of Tables: 50
  • No of Figures: 250

Global Contrast Media Injectors Market – Industry Trends and Forecast to 2029

Market Size in USD Billion

CAGR - % Diagram

Diagram Forecast Period 2021–2029
Diagram Market Size (Base Year) USD 1.40 Billion
Diagram Market Size (Forecast Year) USD 2.50 Billion
Diagram CAGR %

Global Contrast Media Injectors Market, By Type (Single Head, Dual-Head, Syringeless Injectors), Product (Injector Systems, Consumables), Application (Radiology, Interventional Cardiology, Interventional Radiology), End-User (Hospitals, Ambulatory Surgical Centres, Diagnostics Centres) – Industry Trends and Forecast to 2029.

Market Analysis and Size

Rising number of research and development proficiencies is bringing in innovations in the media injector systems. Increasing number of scientists and researchers conducting their research studies pertaining to the tissue analysis has widened the scope of growth for the market.  “Injector Systems” dominates the product segment of the contrast media injectors market owing to the increasing development and launch of new vaccines and a robust pipeline and increasing personal disposable income.                               

  • Data Bridge Market Research analyses that the contrast media injectors market is expected to undergo a CAGR of 7.75% during the forecast period. This indicates that the market value, which was USD 1.40 billion in 2021, would rocket up to USD 2.50 billion by 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Contract media injectors are the injectable, injected into the body with an aim to look at a better image of tissues for medical imaging procedures. Also known as power injectors, the contrast media injectors are used for a wide range of therapeutic and diagnostic procedures.   

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Type (Single Head, Dual-Head, Syringeless Injectors), Product (Injector Systems, Consumables), Application (Radiology, Interventional Cardiology, Interventional Radiology), End-User (Hospitals, Ambulatory Surgical Centres, Diagnostics Centres)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

Boehringer Ingelheim International GmbH (Germany), Sanofi (France), Novartis AG (Switzerland), Merck Sharp & Dohme Corp. (Germany), Bracco Imaging S.p.A. (Italy), Guerbet (France), Medtron AG (Germany), Bayer AG (Germany), ulrich medical (Germany), GENERAL ELECTRIC COMPANY (US), VIVID IMAGING (US), Sino Medical Sciences Technology Inc. (China), AngioDynamics (US), APOLLO RT Co. Ltd (US), Nemoto (Japan), Messe Düsseldorf GmbH (Germany), Hilin Life Products, Inc. (US), Jodas Expoim (India), Lantheus Medical Imaging, Inc (US), Magnus Health (US), TAEJOON PHARM (South Korea) and Spago Nanomedical AB (Sweden)  

Contrast Media Injectors Market Dynamics

Drivers

  • The rise in the prevalence of diseases

Surging prevalence of chronic and acute diseases and disorders in individuals all around the globe that require early diagnosis and on-time treatment for prevention of complications is one of the major factors responsible for fostering growth in the market value. Rising incidence rate of cancer, physical injury, stroke, heart disease, vascular disease, digestive disorder and many more is directly propelling the market growth rate.    

  • Research and development proficiencies

Rising expenditure for research and development proficiencies especially in the developed and developing economies pertaining to the medical instruments and devices will further create lucrative market growth opportunities. According to World Health Organization in 2021, cardiovascular diseases accounted the top position for being responsible for the highest number of deaths globally.

  • Government investments on healthcare infrastructure

The increase in the funding by the federal government is set to drive the market growth rate. Moreover, growth and expansion of healthcare industry being driven by both public and private players especially in the developing economies will create lucrative market growth opportunities.

Additionally, surge in the personal disposable income level, increasing demand for minimally invasive surgeries and increasing investment for the development of advanced, governmental support in approving the medical technology, positively affect the market growth rate.

Opportunities

Furthermore, upsurge in the public-private funding for target research activities, regulatory approval of a growing number of contrast agents and rising product innovations and development owing to technological advancements all around the world will extend profitable opportunities for the market players in the forecast period of 2022 to 2029. Additionally, surging number of strategic collaborations, rising internet penetration rate, increase in the number of public and private diagnostic centers, technological and biotechnological advancements regarding diagnostics and therapeutics in the developing regions and increasing per capita expenditure on health care will further expand the market's growth rate in the future. 

Restraints/Challenges

On the other hand, high cost associated with the research and development proficiencies, limited infrastructural facilities and increased cost of contrast media injectors, consumables, and accessories are expected to obstruct market growth. Also, lack of favourable reimbursement scenario and technology penetration in the developing economies, rising risks associated with contrast media injectors, lack of skilled medical professionals in the developing and underdeveloped regions and lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2022-2029.

This contrast media injectors market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the contrast media injectors market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Contrast Media Injectors Market

COVID-19 has significantly and negatively impacted the market. The funding for research and development activities was significantly reduced and cut down. Supply chain disruptions demoted the market demand and supply. There was a huge postponement on the non-essential medical procedures. Significant disruptions experienced by their respective manufacturing and supply-chain operations as a result of various precautionary lockdowns has further worsened the situation. Further, radiology departments have experienced a rapid decline in imaging case volume has forther derail the market growth rate. All of this proved to be a bane for the market during pandemic.

Recent Development

  • In December 2021, Guerbet and Bracco Imaging, has announced to signed a global collaboration for Gadopiclenol, a next-generation magnetic resonance imaging (MRI) contrast agent.
  • In December 2021, Qaelum NV has announced strategic partnership with ulrich GmbH & Co. KG in Ulm to combine their advanced Contrast Management solution with the contrast media injectors of ulrich medical, to support the needs of hospitals and imaging networks.

 Global Contrast Media Injectors Market Scope

The contrast media injectors market is segmented on the basis of type, product, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Single Head
  • Dual-Head
  • Syringeless Injectors

On the basis of type, the contrast media injectors market is segmented into single head, dual-head and syringeless injectors.

Product

  • Injector Systems
  • Consumables

Based on product, the contrast media injectors market is segmented into injector systems and consumables Injector systems have been further segmented into CT injector systems, MRI injector systems and angiography injector systems. Consumables have been further segmented into injector heads, syringes, tubing, other consumables and accessories.

Application  

  • Radiology
  • Interventional Cardiology
  • Interventional Radiology

Based on application, the contrast media injectors market is segmented into radiology, interventional cardiology and interventional radiology.

End-user

  • Hospitals
  • Ambulatory Surgical Centres
  • Diagnostics Centres

The contrast media injectors market is also segmented on the basis of end-user into hospitals, ambulatory surgical centres and diagnostics centres. 

Contrast Media Injectors Market Regional Analysis/Insights

The contrast media injectors market is analysed and market size insights and trends are provided by country, type, product, application and end-user as referenced above.

The countries covered in the contrast media injectors market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the contrast media injectors market because of the strong base of healthcare facilities, rising availability of advanced IT-enabled solutions for data management, and rising number of research activities in this region.   

Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increase in government initiatives to promote awareness, rising cases of cancer, orthopedic diseases, epilepsy, and Alzheimer's disease and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The contrast media injectors market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for contrast media injectors market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the contrast media injectors market. The data is available for historic period 2010-2020.

Competitive Landscape and Contrast Media Injectors Market Share Analysis

The contrast media injectors market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to contrast media injectors market.

Some of the major players operating in the contrast media injectors market are Boehringer Ingelheim International GmbH (Germany), Sanofi (France), Novartis AG (Switzerland), Merck Sharp & Dohme Corp. (Germany), Bracco Imaging S.p.A. (Italy), Guerbet (France), Medtron AG (Germany), Bayer AG (Germany), ulrich medical (Germany), GENERAL ELECTRIC COMPANY (US), VIVID IMAGING (US), Sino Medical Sciences Technology Inc. (China), AngioDynamics (US), APOLLO RT Co. Ltd (US), Nemoto (Japan), Messe Düsseldorf GmbH (Germany), Hilin Life Products, Inc. (US), Jodas Expoim (India), Lantheus Medical Imaging, Inc (US), Magnus Health (US), TAEJOON PHARM (South Korea) and Spago Nanomedical AB (Sweden) among others.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Contrast Media Injectors Market will be projected USD 2.50 billion during the forecast period of 2022 to 2029.
The Contrast Media Injectors Market is Projected to Grow at a CAGR of 7.75% in the Forecast Period of 2022 to 2029.
Factors such as the increasing number of pet animals, rising prevalence of animal diseases and increasing personal disposable income are the major growth driving factors of the Contrast Media Injectors Market.
Boehringer Ingelheim International GmbH (Germany), Sanofi (France), Novartis AG (Switzerland), Merck Sharp & Dohme Corp. (Germany), Bracco Imaging S.p.A. (Italy), Guerbet (France), Medtron AG (Germany), Bayer AG (Germany), ulrich medical (Germany), TAEJOON PHARM (South Korea) and Spago Nanomedical AB (Sweden) are the major companies operating in Contrast Media Injectors Market.
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials